Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621933 · ClinicalTrials.gov registry record
Surveillance of Ocular Surface Flora (SURFACE)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 399
- Enrollment target
NCT00621933 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 399 participants.
The verdict
NCT00621933 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
Study Summary
Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance of ocular isolates to commonly used topical antibiotics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621933
The ClinicalTrials.gov registry entry for NCT00621933 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00621933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00621933 about?
NCT00621933 is a clinical study titled "Surveillance of Ocular Surface Flora (SURFACE)". Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance ...
What is the current status of trial NCT00621933?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2007-12. Estimated completion is 2008-11.
Who is sponsoring clinical trial NCT00621933?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.